Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces 2013 Operating Results

CALABASAS, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its quarter and year ended December 31, 2013, and provided...
March 10, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Acquires Rights to ATX-101 Outside of the U.S. and Canada From Bayer Consumer Care

KYTHERA Now Holds Global Rights to ATX-101 KYTHERA to Host Conference Call Today at 4:30 ET CALABASAS, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH)...
March 10, 2014 09:25 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release 2013 Operating Results

CALABASAS, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its fourth quarter and full year 2013 operating results and will...
February 28, 2014 16:33 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference

CALABASAS, Calif., Feb. 28, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Cowen...
January 06, 2014 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at 32nd Annual J.P. Morgan Healthcare Conference

CALABASAS, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the 32nd...
December 19, 2013 17:50 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index

CALABASAS, Calif., Dec. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:NBI),...
November 14, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Third Quarter 2013 Operating Results

LOS ANGELES, Nov. 14, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2013, and provided an update on recent...
November 01, 2013 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release Third Quarter 2013 Operating Results

CALABASAS, Calif., Nov. 1, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its third quarter 2013 operating results and will host an investor...
October 08, 2013 19:44 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

CALABASAS, Calif., Oct. 8, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the pricing of an underwritten public offering of 2,622,950 shares of its common...
October 07, 2013 16:02 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Proposed Public Offering of Common Stock

CALABASAS, Calif., Oct. 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has commenced an underwritten public offering of shares of its common stock to...